Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alacramyn in Pediatric Scorpion Sting Envenomation
NCT01599936Phase 3Completed
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Start
- Apr 2004
- Primary completion
- Oct 2006
- Modality
- Antibody Fragments
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of centruroides (scorpion) immune F(ab')₂ (equine) in scorpion envenomation, sponsored by Instituto Bioclon S.A. de C.V. Primary endpoint: Resolution of clinically important systemic signs of scorpion envenomation at 4 hours. Started Apr 2004; status: completed.
02
Drugs
centruroides (scorpion) immune F(ab')₂ (equine)
03
Conditions
scorpion envenomation
Beyond the preview
Go deeper on NCT01599936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599936.